epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Auvi-Q
    epinephrine (adrenaline)
  • remove brompheniramine/ dextromethorphan/ pseudoephedrine
    generic
  • remove Vanacof
    dexchlorpheniramine/ chlophedianol/ pseudoephedrine
  • remove Vasculera
    diosmiplex

multicheck MultiCheck Results - 7 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face brompheniramine/dextromethorphan/pseudoephedrine (generic) + Vanacof (dexchlorpheniramine/ chlophedianol/ pseudoephedrine)

Avoid/Use Alternative


pseudoephedrine + pseudoephedrine

avoid combo: combo may incr. risk of HTN, other cardiovascular and CNS stimulatory effects (additive effects, duplicate therapy)

Caution Advised


brompheniramine + chlophedianol

caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

brompheniramine + dexchlorpheniramine

caution advised: combo may incr. risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

Monitor/Modify Tx

Smiley face Smiley face Auvi-Q (epinephrine (adrenaline)) + brompheniramine/dextromethorphan/pseudoephedrine (generic)

Monitor/Modify Tx


epinephrine + brompheniramine

monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

epinephrine + pseudoephedrine

monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

Smiley face Smiley face Auvi-Q (epinephrine (adrenaline)) + Vanacof (dexchlorpheniramine/ chlophedianol/ pseudoephedrine)

Monitor/Modify Tx


epinephrine + dexchlorpheniramine

monitor HR, ECG: combo may incr. risk of tachycardia, cardiac arrhythmias (additive effects)

epinephrine + pseudoephedrine

monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

Additional Considerations

Smiley face Smiley face pseudoephedrine in brompheniramine/dextromethorphan/pseudoephedrine, Vanacof

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face epinephrine in Auvi-Q

nasal epinephrine use: caution advised with nasal drugs, including subsequent nasal epinephrine doses, up to 2 wk after initial administration; nasal epinephrine may incr. systemic absorption of nasal drugs, risk of adverse effects

Smiley face Smiley face dextromethorphan in brompheniramine/dextromethorphan/pseudoephedrine

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information